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The current study examined the presence of abnormalities in cortical grey-matter (GM) in a sample of
clinical high-risk (CHR) participants and examined relationships with psychosocial functioning and
neurocognition. CHR-participants (n¼ 114), participants who did not fulfil CHR-criteria (CHR-negative)
(n¼ 39) as well as a group of healthy controls (HC) (n¼ 49) were recruited. CHR-status was assessed
using the Comprehensive Assessment of At-Risk Mental State (CAARMS) and the Schizophrenia Prone-
ness Interview, Adult Version (SPI-A). The Brief Assessment of Cognition in Schizophrenia Battery (BACS)
as well as tests for emotion recognition, working memory and attention were administered. In addition,
role and social functioning as well as premorbid adjustment were assessed. No significant differences in
GM-thickness and intensity were observed in CHR-participants compared to CHR-negative and HC.
Circumscribed abnormalities in GM-intensity were found in the visual and frontal cortex of CHR-
participants. Moreover, small-to-moderate correlations were observed between GM-intensity and neu-
ropsychological deficits in the CHR-group. The current data suggest that CHR-participants may not show
comprehensive abnormalities in GM. We discuss the implications of these findings for the pathophysi-
ological theories of early stage-psychosis as well as methodological issues and the impact of different
recruitment strategies.
© 2019 Published by Elsevier B.V.1. Introduction
Abnormalities in grey matter (GM) are an established neuro-
anatomical feature of schizophrenia (ScZ) that have been disclosed
throughmagnetic resonance imaging (MRI) (Smieskova et al., 2010;
Lawrie et al., 1997, 1999; Bois et al., 2015; Shenton et al., 2001).
Specifically, reductions in GM thickness (Ward et al., 1996; Wright
et al., 2000; Kuperberg et al., 2003) have been observed that
correlate with certain symptoms of psychosis and neurocognitive
impairments (Antonova et al., 2003; Szesko et al., 2003; Zuffanteand Psychology, 58 Hillhead
ey-matter abnormalities in cet al., 2001). Meta-analytic studies have indicated that regions
most prominently implicated in ScZ are frontal and temporal
cortices (Brent et al., 2014; Gur et al., 2007; Honea et al., 2005).
GM-abnormalities in ScZ have been related to excessive pruning
of synaptic contacts during adolescence (Feinberg, 1982) as well as
aberrant organization of synaptic connections caused by the atyp-
ical migration of the neuron precursor cells during gestation
(Cannon et al., 2003; Keshavan et al., 1994). Conflicting evidence
exists regarding the trajectory of GM-abnormalities. It has been
proposed that reductions in GM-volume are progressive during the
early stages of ScZ (Shenton et al., 2001; McCarley et al., 1999;
Kubicki et al., 2002). However, other studies could not support this
finding (Tognin et al., 2014). More recent evidence has also high-
lighted the possible role of long-term anti-psychotic medication as
a contributing factor towards GM-abnormalities in ScZ (Kato et al.,linical high-risk participants for psychosis, Schizophrenia Research,
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An important question is the presence of volumetric and
thickness GM-differences in participants at clinical high-risk (CHR)
for ScZ. CHR-criteria have been developed based on the presence of
attenuated psychotic symptoms (Miller et al., 2003; Yung et al.,
2005) as well as in relationship to the basic symptom (BS)
concept proposed by Huber and colleagues (Schultze-Lutter et al.,
2012). BS involve the presence of self-experienced perceptual and
cognitive anomalies that are thought to represent the earliest
manifestation of psychosis risk (Schultze-Lutter et al., 2012).
Overall, CHR-criteria confer a approximately a 20% risk of devel-
oping ScZ within a 2 year period (Fusar-Poli et al., 2016). Moreover,
psychosis-risk varies among CHR-subgroups with participants
experiencing brief limited intermittent psychotic symptoms (BLIPS)
showing the highest transition rates (Kempton et al., 2015;Fusar-
Poli et al., 2016).
There is extensive evidence on the presence of GM-deficits in
help-seeking CHR-populations with reductions in GM-volume and
thickness in PFC, temporal cortex and parietal cortices (Job et al.,
2005; Jung et al., 2010; Koutsouleris et al., 2009, 2010a, 2010b;
Borgwardt et al., 2009). GM-deficits have also been found to
correlate with impaired neurocognition (Koutsouleris et al., 2010a,
2010b) and more pronounced positive symptoms in CHR-cohorts
(Iwashiro et al., 2012). Moreover, there is evidence for GM re-
ductions in subcortical areas, such as basal ganglia, vermal and
cerebellar lobules (Koutsouleris et al., 2015; Koutsouleris et al.,
2012; Wood et al., 2013; De Wit et al., 2017). However, several
studies (Klauser et al., 2015; Takahashi et al., 2008; Velakoulis et al.,
2006; Ziermans et al., 2009) also failed to find abnormalities in GM
in CHR-groups, raising the question whether neuroanatomical
deficits are a pervasive feature of emerging psychosis.
Reductions in GM-volume may differentiate between the CHR-
participants who convert to psychosis vs. those who do not
(Brent et al., 2013; Koutsouleris et al., 2010a, 2010b; Pantelis et al.,
2003). Significant decreases of GM-volume in PFC and temporal
cortices as well as in limbic areas and cerebellum were associated
with transition to psychosis (Smieskova et al., 2010; Sun et al.,
2009; Hunter and Lawrie, 2018). In addition, voxel-based
morphometry (VBM) studies further revealed anterior cingulate,
parahippocampal and precuneus GM loss among converters (Fusar-
Poli et al., 2011). In contrast, there is also evidence for circum-
scribed GM-increases in CHR-participants who develop psychosis,
primarily in limbic areas (Mechelli et al., 2011; Garner et al., 2005).
In the current study, we examined the presence of GM-
abnormalities in a sample of 114 CHR-participants that were
recruited as part of the Youth Mental Health Risk and Resilience
Study (YouR-study) (Uhlhaas et al., 2017). Neuroanatomical ab-
normalities in psychiatric conditions are often studied using VBM,
a structural neuroimaging technique for comparing regional brain
volumes differences (Fusar-Poli et al., 2011; Radua et al., 2010;
Bora et al., 2012; Honea et al., 2005; Ashburner and Friston, 2000).
In VBM analysis, several transformations are applied to the orig-
inal anatomical data and some of these have been associated with
a substantial decrease in the sensitivity to detect GM-
abnormalities (Radua et al., 2014). As a result, GM-alterations
cannot be easily related to cortical thinning or a decrease in
contrast within GM.
In the current study, we employed a whole-brain approach that
involved themeasurement of GM-intensity in 70 regions of interest
(ROIs). We analyzed MRI-data at the individual level with a ROI
based approach that preserved participant-specific topology
allowing to independently study local GM intensity as well as
cortical thickness. Similar approaches have been used in recent
studies on in-vivo myelination (Rowley et al., 2017; Hashim et al.,
2015).Please cite this article as: Zikidi, K et al., Grey-matter abnormalities in c
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2.1. Recruitment and participants
The YouR-Study is a longitudinal study to identify neurobio-
logical and psychological mechanisms and predictors of psychosis-
risk (Uhlhaas et al., 2017) and is funded by the Medical Research
Council (MRC). CHR-participants were recruited from the commu-
nity (n¼ 114) through an online-screening approach (McDonald
et al., 2018). In brief, CHR-participants were recruited through a
website (see http://www.your-study.org.uk) that identified CHR-
participants from the general population through email-
invitations, posters and flyers. Specifically, email invitations were
sent out to colleges and universities in Glasgow and Edinburgh
through which the majority of study participants were identified.
Participants then filled out the online-versions of the a) the 16-item
Prodromal Questionnaire (PQ-16) (Ising et al., 2012) and b) a 9-item
scale of perceptual and cognitive anomalies (PCA) that was devel-
oped to assess BS. Participants were invited for clinical interviews if
they positively endorsed 6 or more items on the PQ-16 or 3 or more
on the PCA. Moreover, n¼ 8 CHR-participants were recruited from
clinical services through referrals.
In addition, a group of participants (n¼ 39) who did not meet
CHR-criteria but were characterized by non-psychotic psychiatric
conditions, such as substance abuse and affective disorders, was
included.
The positive scale of the Comprehensive Assessment of At-Risk
Mental States (CAARMS) (Yung et al., 2005) was administered as
well as 14 items of the Schizophrenia Proneness Instrument (SPI-A)
(Schultze-Lutter et al., 2007) to determine Cognitive-Perceptive
Basic Symptoms (COPER) and Cognitive Disturbances (COGDIS)
criteria. CAAMRS/SPI-A interviews were conducted by trained
research assistants andMS.c./Ph.D. level-researchers. Moreover, the
M.I.N.I. International Neuropsychiatric Interview (M.I.N.I. 6.0)
(Sheehan et al., 1998), the scales for premorbid adjustment
(Cannon-Spoor et al., 1982) and social and functional role scales
(Cornblatt et al., 2007) were administered. Neuropsychological
assessments included the Brief Assessment of Cognition in
Schizophrenia (BACS), Keefe et al., 2004).
2.2. MRI-data collection and pre-processing
2.2.1. Acquisition
MRI-data were acquired from n¼ 225 participants of which
n¼ 202 participants were used in the final analysis. T1 weighted
(T1-w) scans obtained using a 3 T MPRAGE sequence
(FoV¼ 256x256x176 mm3, voxel size ¼1x1x1 mm3, TR¼ 2250ms,
TE¼ 2.6ms, T1¼900ms, FA¼ 9).
2.2.2. Processing and segmentation
T1-w volumes were up-sampled to 0.7mm isotropic to aid the
precision of the automatic segmentation. Up-sampling was per-
formed using the AFNI function 3dresample, with linear interpo-
lation (afni.nimh.nih.gov).
Prior to removing the skull, the intensity of T1-w volumes was
normalized to remove global inhomogeneities using the AFNI’s
3dUnifize. The skull was removed from each T1-w anatomy using
the AFNI’s 3dSkullStrip. The mask obtained was slightly dilated
using the AFNI’s 3dmask_tool (dilate_input parameter set to 1) to
prevent unwanted erosion of the external portion of GM.
The skull from the un-normalized T1-w volume was removed
using the obtained skull stripping mask. At this point the T1-w
volume was normalized using AFNI’s 3dUnifize. We performed
this normalization step on the skull-stripped data to focus the in-
homogeneity correction only within the cerebrum.linical high-risk participants for psychosis, Schizophrenia Research,
K. Zikidi et al. / Schizophrenia Research xxx (xxxx) xxx 3GM and white matter (WM) were segmented on each processed
T1-w anatomy using MIPAV v7.4 software (mipav.cit.nih.gov) with
the JIST v3.0 (www.nitrc.org/projects/jist/), TOADS-CRUISE vR3c
(www.nitrc.org/projects/toads-cruise, Fig. 1A/B).
GM and WM masks were used as input to the volumetric
layering tool in CBS-tools (CBS High-Res Brain Processing Tools
Version v3.0, www.nitrc.org/projects/cbs-tools). We built an equi-
volume map from the WM-GM interface to the GM-cerebrospinal
fluid (CSF) interface (Waehnert et al., 2014, see Fig. 1C), providing
a normalized reference frame for the location of each voxel across
cortical depth from 0 (the WM-GM interface) to 1 (the GM-CSF
interface). An estimate of local curvature and cortical thickness
was obtained for each voxel within GM.
GM-values of each participant were extracted and detrended for
local curvature and cortical thickness (Sereno et al., 2012). The
obtained residuals were z-scored and stored in a volume in the
same individual T1-w space.
It is important to note that the obtained z-scored GM values
were centred on 0, representing the individual T1-w average.
Values that positively depart from zero as well as values that
negatively depart from zero indicate differences with respect to the
mean T1-w, hence higher signal contrast with respect to the mean.
On the other hand, values that are closer to zero indicate signal
close to the mean T1-w signal, hence lower signal contrast with
respect to the mean.
For visualization purposes, 3 surfaces were build based on each
T1-w anatomy segmentation, one surface at the WM-GM interface,
one surface in the middle of cortical depth and the last surface at
the GM-CSF interface (see Fig. 1 D-I). Surfaces were generated from
a binarized version of the equi-volume map at the desired level,
using the AFNI function IsoSurface.
2.2.3. Atlas co-registration
Each processed T1-w anatomy was co-registered to a stan-
dardized talaraich space provided in AFNI (TT_Daemon) using an
affine transformation. The probabilistic volumetric Desikan-Killiani
atlas (Desikan et al., 2006) was interpolated in each participant T1-
w space using nearest-neighbour interpolation. The range ofFig. 1. Processing and segmentation. A: T1-w contrast, coronal slice from a single participan
to a coronal slice, T1-w contrast, single participant. C: equi-volume cortical depth map super
surface and grey matter/cerebro-spinal fluid surface superimposed to a coronal slice, T1-w c
same as panel D, surfaces superimposed to a horizontal slice, T1-w contrast. G: whole brain s
linear interpolation from a single participant. White arrows indicate motor cortex and so
myelination of this location compared to neighbouring location (Glasser & Van Essen., 2011;
T1-w signal at the level or the calcarine fissure (white arrows in the posterior part of the
matosensory cortex. I: same as H, rotated view.
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degree of overlap measured in the original atlas (Desikan et al.,
2006). For this reason, we adopted the following criteria to select
the voxels in each ROI. For each volumetric ROI and participant, we
selected the GM voxels associated with probabilistic values larger
than the 25% quantile of the probabilistic ROI itself and located
within a cortical depth of 0.4 and 0.6.
From the selected voxels, the average of the detrended z-scored
GM values was computed as well as the average local cortical
thickness.
2.2.4. Data analysis
Z-scored GM and cortical thickness estimates for each partici-
pant and ROI were stored in a long-format table, together with the
ROI hemisphere (left or right) and demographics variables age and
gender and the experimental group (3 levels: controls, CHR and
CHR-negative). Furthermore, each ROI was assigned to one of 4
lobes: frontal, parietal, temporal and occipital.
Data analysis on the anatomical dependent variables was per-
formed with a linear mixed effects model implemented in R (www.
r-project.org) with the package nlme (Pinheiro et al., 2018). In a
linear mixed effect, model the significance of a parameter, or the
contrast between two levels in a parameter, is performed using a
conditional F-test (Pinheiro and Bates, 2000).
We tested for a modulation of the anatomical dependent vari-
ables along the experimental group. The inputs to the model were
(as fixed effects): experimental group, lobe, hemisphere, age and
gender, allowing for interactions between the terms (hemisphere,
age and gender were included as covariates). Each individual
participant was modelled as a random effect with a variable
intercept.
To test for group-differences, we used a separate linear model
for each of the 4 lobes (see Fig. 2). The coefficients of the CHR- and
CHR-negative were computed relative to the intercept condition of
the control group and corrected for multiple comparisons. The
same approach was used to examine CHR-subgroups (CAARMS/
CHR, SPI-A/CHR, CHR-Combined). Post-hoc analyses were run using
t-tests (two-tails).t, skull removed. B: white matter and grey matter segmentation results, superimposed
imposed to a coronal slice, T1-w contrast. D: white matter/grey matter surface, middle
ontrast. E: same as panel D, surfaces superimposed to a sagittal slice, T1-w contrast. F:
urface reconstruction (middle surface), T1-w contrast is mapped over the surface using
matosensory cortex, showing remarkably high T1-w signal, indicative of the higher
Sereno et al., 2012; Fracasso et al., 2016). H: same as panel G, angled view shows high
brain). White arrows in the superior part of the brain indicate motor cortex and so-
linical high-risk participants for psychosis, Schizophrenia Research,
Fig. 2. z-scored grey matter (GM) across separate lobes and experimental groups. A: z-scored GM in different lobes for controls (CON), and clinical-high risk (CHR) and CHR-
negative (CHR-N) groups. Z-scores are centred on 0, values that depart from zero (either positively or negatively) represent departures with respect to the average T1-w signal.
Thus are indicative of higher signal contrast with respect to the average. The occipital lobe shows the highest z-scores as can be expected based on the known high myelination of
this location (Glasser & Van Essen 2011; Sereno et al., 2012; Fracasso et al., 2016); the lowest values can be observed in the frontal lobe. The analysis showed a significant modulation
of z-scored GM between the CHR-group and controls in the frontal lobe (see red dashed lines). Other comparisons in different lobes did not survive multiple correction. B: z-scored
GM in different lobes for controls (CON), CHR-negative (CHR-N), CHR-CAARMS/SPI-A (CHR_combined), CHR-CAARMS (CHR-CAARMS) and CHR-SPI-A (CHR-SPI-A) groups. The
analysis showed a significant modulation of z-scored GM between CHR-CAARMS and controls in the occipital lobe (see red dashed lines). Comparisons in other lobes did not survive
multiple correction(see main text for details).
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The average z-scored GM across participants for each ROI was
projected back into the standardized talaraich space. The average z-
scored GM was computed for each experimental group. The ob-
tained average z-scored GM volumes were map on a standardized
surface using AFNI-SUMA with linear interpolation over surfaces
nodes (see Fig. 3).
3. Results
3.1. Sample characteristics
Of the n¼ 86 participants which met CAARMS-criteria, n¼ 84
met APS and 2 genetic/functional decline criteria. The CHR-group
had significantly higher CAARMS-positive severity scores,
reduced GAF scores as well as lower role and social functioning
compared to HC and CHR-negatives (Table 1). There was extensive
psychiatric comorbidity in the CHR-group, in particular in regards
to affective and anxiety disorders. Compared to the CHR-N group,
anxiety, mood disorders, suicide risk, OCD and alcohol dependence/
abuse were more pronounced in the CHR-participants.
Analyses of neuro-cognitive performance for CHRs, CHR-
negatives and HCs revealed significant deficits in motor speed
(d¼ 0.38) as well as for the BACS composite score (d¼ 0.35) in the
CHR-group relative to HC. Moreover, differences between CHR-
subgroups were explored (Supplementary Material Table 1).
3.2. Neuroanatomical outcomes
GM-intensity: The linear mixed effects model on z-scored GM
across CHR-, CHR-negative and HC showed a significant interactionPlease cite this article as: Zikidi, K et al., Grey-matter abnormalities in c
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linear models showed a significant modulation between the CHR-
group and HC in the frontal lobe (T¼ 2.73, p< 0.01), indicating a
decreased T1-w signal contrast in CHR-participants. Effects for oc-
cipital, parietal and temporal lobes did not reach statistical
significance.
Analysis of CHRs-subgroups revealed an interaction effect be-
tween groups and lobes (F¼ 3.21, p< 0.001). The linear model
showed a significant modulation of z-scored GM between CHR-
CAARMS and HC in the occipital lobe (T¼ -2.25, p< 0.05), indi-
cating a lower T1-w signal contrast in the CHR-CAARMS group.
To further investigate this difference, we visually inspected the
surfaces of visual cortices and performed post-hoc tests. The largest
signal modulation was localized around the pericalcarine cortex
and the lingual gyrus (T¼ -2.28, p< 0.05 and T¼ -2.90, p< 0.01,
respectively) and did not extend to neighbouring locations, such as
the cuneus, the parahippocalmpal gyrus and the lateral-occipital
cortex (T¼ -0.51, T¼ -0.83 and T¼ -1.52, n.s., respectively, see
Fig. 3). It is important to note that we used surfaces only for visu-
alization purposes. The statistical analysis is performed on the ROI
based analysis on each individual T1-w native space.
Cortical Thickness: There was no significant interaction effect
between groups and lobes for the contrast between CHR-, CHR-
negatives and HCs.
Correlations with neuropsychological and demographic vari-
ables: We explored systematic correlations between neuropsy-
chological scores, clinical and GM-thickness and intensity by
including demographical variables as covariates in a linear regres-
sion model. No significant correlations were observed between
GM-thickness, GAF, BACS total score and CAARMS-ratings across
the whole brain or in any of the four cortical lobes (Supplementarylinical high-risk participants for psychosis, Schizophrenia Research,
Fig. 3. z-scored grey matter (GM) modulation between controls and CHR-CAARMS group in the occipital lobe, standardized surfaces. A: control group, right and left hemispheres,
respectively, medial view. High intensity average z-scored are visible at the level of the calcarine fissure (white arrows). B: same as A, but for CHR-CAARMS group. Even though z-
scored GM values are higher around the calcarine fissure in this group, overall intensity appears lower compared to the control group (panel A).
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Similarly, correlations between GM-intensity, CAARMS-scores
and GAF were not significant when corrected for multiple com-
parisons. However, correlations between GM-intensity and total
GAF reached statistical trend levels for the parietal and frontal lobes
in CHR-participants (Supplementary Material Table 3).
4. Discussion
We examined whole-brain GM-signal intensity and cortical
thickness in a CHR-cohort that was largely recruited from the
general community. Overall, we did not observe alterations in GM
across cortices in CHR-participants. Circumscribed alterations were
found in the frontal cortex for the CHR-sample as well as for a
subgroup of CHR-participants with attenuated psychotic symptoms
in the occipital lobe. In addition, changes in GM-intensity only
moderately correlated with neurocognitive impairments.
The decreased T1-contrast in the frontal lobe of CHR-
participants could be associated with different processes. Struc-
tural abnormalities have been identified in ScZ, particularly in
supra-granular layers, involving changes in pyramidal cell density
and thinning in the dorso-lateral prefrontal cortex (Jakob and
Beckmann, 1994, Kalus et al., 1997, Selemon et al., 1995, Cullen
et al., 2006). Moreover, ScZ has been associated with higher
neuronal density within GM in frontal and occipital lobes (Selemon
et al., 1995).
However, it is not clear how these GM abnormalities observed in
ex-vivo samples might transfer to in-vivo T1 contrast. T1 contrast is
a complex signal that reflects differences in lipid concentration
associated with myelin and is heavily influenced by iron content
(Koenig, 1991; Fukunaga et al., 2010; Stueber et al., 2014). Accord-
ingly, it is not possible to identify a single signal source responsible
for the observed T1-alteration in the frontal cortex in CHR-
participants.
The decreased T1-contrast in the frontal lobe of CHR-Please cite this article as: Zikidi, K et al., Grey-matter abnormalities in c
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examined across CHR-subgroups. Instead, CHR-participants with
predominant attenuated psychotic symptoms were characterized
by a reduction of GM-intensity values in the occipital cortex,
involving the pericalcarine cortex and the lingual gyrus. The lower
GM-intensity suggests lower T1-contrast that could potentially
index abnormal organization of visual areas.
While phenomenological evidence has highlighted that visual
dysfunctions may play a key role in the development of psychosis
(Uhlhaas and Mishara, 2006; Klosterk€otter et al., 2001), little evi-
dence for anatomical and functional alterations in the visual system
exist in CHR-participants (Zhao et al., 2018; Tohid et al., 2015;
Nieuwenhuis et al., 2012). This contrasts with a considerable
body of work in established ScZ using psychophysical (Yoon et al.,
2009; Uhlhaas and Silverstein, 2005; Uhlhaas & Tan et al., 2013),
electrophysiological (Javitt et al., 2000; Butler et al., 2001; Grent-T-
Jong et al., 2016) as well as anatomical approaches (Dorph-Petersen
et al., 2007; Wagstyl et al., 2016) which have highlighted the
contribution of aberrant visual processing in the pathophysiology
of ScZ.
It should be noted, however, that differences in the visual sys-
tem were only found in a subgroup of CHR-participants with pre-
dominantly attenuated psychotic symptoms, raising the possibility
that CHR-participants may be characterized by distinct neurobio-
logical signatures. Future studies need to determine whether there
may be stage-specific anatomical alterations during the emergence
of psychosis as changes in GM-intensity were not observed in CHR-
participants with BS, for example, that also involve alterations in
sensory processing that may precede the development of psychotic
phenomena (Schultze-Lutter et al., 2012).
The novel observation of circumscribed alterations in GM-
intensity in visual cortices may be related to the methodological
approach employed in the current study. The majority of studies
into GM-changes in CHR-groups and in ScZ have employed a VBM-
approach. In VBM analysis, anatomical scans are registered to alinical high-risk participants for psychosis, Schizophrenia Research,
Table 1
Baseline demographic characteristics of CHR, HC and CHR-negative participants.
Characteristic CHRs
(N¼ 114)
HCs
(N¼ 49)
CHR-Ns
(N¼ 39)
df F/ X2 p Post-hoc contrast
Age (years), M± SD 21.68± 4.48 22.49± 3.57 22.74± 4.59 2 F¼ 1.16 0.31 e
Gender, Female (%) 85 (74.5%) 33 (67.3%) 26 (66.6%) 2 F¼ 0.68 0.50 e
Years of education, M± SD 15.27± 3.24 16.63± 3.03 16.46± 3.44 2 F¼ 3.94 0.02 HCs vs CHRs
GAF, median (range) 58 (21e91) 89 (68e97) 70 (43e84) 2 F¼ 164.53 <0.001 HCs vs CHR-Ns vs CHRs
CRH-Diagnosis
CAARMS 35
SPI-A 28
CAARMS/SPI-A 51
CAARMS-Positive Severity, median (range) 28 (0e72) 0 (012) 6 (0e24) 2 F¼ 154.60 <0.001 HCs vs CHR-Ns vs CHRs
GF: Social, median (range) 8 (5e10) 9 (8e9) 8 (6e9) 2 F¼ 61.35 <0.001 HCs vs CHR-Ns vs CHRs
GF: Role, median (range) 8 (4e9) 9 (5e9) 8 (5e9) 2 F¼ 27.79 <0.001 HCs vs CHR-Ns vs CHRs
PAS, median (range)
Childhood 3 (0e16) 1 (0e6) 2 (0e6) 2 F¼ 24.70 <0.001 HCs vs CHR-Ns vs CHRs
Early adolescence 6 (022) 2 (0e8) 4 (0e14) 2 F¼ 33.44 <0.001 HCs vs CHR-Ns vs CHRs
Late adolescence 5 (020) 2 (010) 4 (013) 2 F¼ 19.66 <0.001 HCs vs CHR-Ns, HCs vs CHRs
Medication, N (%) 54 (47.3%) 17 (43.5%) 2 X2¼ 23.31 <0.001 HCs vs CHRs, HCs vs CHR-Ns
None 60 (52.6%) 22 (56.4%)
Anti-psychotic 1 (0.8%) 0 (0%) 2 F¼ 0.38 0.68 e
Mood stabiliser 3 (2.6%) 0 (0%) 2 X2¼ 2.33 0.31 e
Anti-depressant 36 (31.5%) 13 (33.3%) 2 X2¼ 15.32 <0.001 HCs vs CHRs, HCs vs CHR-Ns
Other 26 (22.8%) 6 (15%) 2 X2¼ 6.75 0.034 HCs vs CHRs
Diagnosis, N (%) 103 (90.3%) 23 (58.9%) 2 X2¼ 101.0 <0.001 HCs vs CHR-Ns vs CHRs
Anxiety disorders 94 (82.4%) 17 (43.5%) 2 X2¼ 92.00 <0.001 HCs vs CHR-Ns vs CHRs
Mood disorders 70 (61.4%) 11 (28.2%) 2 X2¼ 56.36 <0.001 HCs vs CHR-Ns vs CHRs
Eating disorders 12 (10.5%) 1 (2.5%) 2 X2¼ 7.36 0.025 HCs vs CHRs
Suicide Risk 57 (50%) 9 (23%) 2 X2¼ 37.59 <0.001 HCs vs CHRs vs CHR-Ns
Alcohol Dependence/Abuse 32 (28.07%) 10 (25.6%) 2 X2¼ 11.93 0.003 HCs vs CHRs, HCs vs CHR-Ns
Substance Dependence/Abuse 15 (13.1%) 3 (7.6%) 2 X2¼ 7.36 0.025 HCs vs CHRs,
Obsessive Compulsive Disorder (OCD) 16 (14.03%) 0 (0%) 2 X2¼ 13.34 0.001 HCs vs CHRs vs CHR-Ns
Post-Traumatic Stress Disorder (PTSD) 11 (9.6%) 1 (2.5%) 2 X2¼ 6.66 0.036 HCs vs CHRs
BACS (M/SD)
Verbal Memory 0.54/ 1.84 0.12/ 1.37 0.24/ 1.38 2 F¼ 2.80 0.06 e
Motor Speed 0.72/ 1.92 0.07/ 1.21 0.54/ 1.56 2 F¼ 3.75 0.02 HCs vs CHRs
Processing Speed 0.03/ 1.79 0.16/ 1.54 0.12/ 1.53 2 F¼ 0.37 0.68 e
Verbal Fluency 0.09/ 1.36 0.41/ 1.37 0.30/ 1.07 2 F¼ 1.17 0.31 e
Executive Function 0.07/ 1.89 0.05/ 1.41 0.12/ 1.02 2 F¼ 0.21 0.80 e
Working Memory 0.37/ 1.51 0.34/ 1.23 0.37/ 1.98 2 F¼ 0.007 0.99 e
BACS Composite 0.46/ 1.58 0.11/ 1.10 0.21/ 0.99 2 F¼ 3.13 0.04 HCs vs CHRs
K. Zikidi et al. / Schizophrenia Research xxx (xxxx) xxx6standard template and are scaled by the macroscopic trans-
formations to preserve local volumes as well as smoothed to allow
for comparison between samples. There is evidence to suggest that
this approach may lead to a decrease sensitivity to detect GM-
abnormalities (Radua et al., 2014). Moreover, resulting differences
can also not be clearly ascribed to cortical thinning or a decrease in
contrast within GM.
The approach adopted here differs from standard VBM analysis
as T1-data was analyzed at the individual level with an ROI based
approach according to the participant-specific topology that could
have facilitated the detecting of anatomical changes in visual
cortices. Even though the calcarine fissure and the occipito-parietal
sulcus can be identified reliably across individuals, their shape are
characterized by higher inter-subject variability in cortical folding
compared to other brain locations, such as the central sulcus (Tardif
et al., 2015). This local variability in cortical folding can negatively
influence registration approaches that utilize standardized tem-
plates as implemented in VBM, for example, and, as a result affect
the sensitivity to detect GM changes in brain location characterized
by high inter-subject variability in cortical folding, such as in the
visual cortex.
The absence of gross differences in GM in our sample of CHR-
participants is consistent with several recent studies that exam-
ined GM-values in CHR-populations (Klauser et al., 2015;
Ziermans et al., 2010), suggesting that GM-anomalies across
cortical regions may not be a pervasive feature of emerging
psychosis. Similar to the findings by Klauser et al. (2015), wePlease cite this article as: Zikidi, K et al., Grey-matter abnormalities in c
https://doi.org/10.1016/j.schres.2019.08.034recruited a sample of CHR-participants who were largely self-
referred outside specialised clinics for emerging psychosis.
There is evidence that CHR-participants who are not recruited
through clinical referral pathways may be characterized by
reduced transition rates (Fusar-Poli et al., 2015a, 2015b) as well as
by subtle differences in the profile of neuropsychological deficits
(McDonald et al., 2018). Accordingly, our recruitment approach
adopted in this study may have contributed to a CHR-sample
characterized by a lower amount of accumulated risk factors for
developing psychosis (Fusar-Poli & Schultze-Lutter, 2016; Fusar-
Poli et al., 2015a,b; Radua et al., 2018). However, follow-up data
are needed to address this question.
Our data suggest changes in GM-intensity may only moderately
correlate with impairments in neurocognition. Previous studies
(Brewer et al., 2006; Lencz et al., 2006; Jung et al., 2010) reported
relationships between GM-impairments and impaired cognition in
CHR-samples. Interestingly, no significant correlations were
observed for correlations with clinical variables, such as psychotic
symptom expression.
Finally, the number of female CHR-participants in the current
study exceeded previous studies in the field. There is evidence to
suggest that anatomical abnormalities may be more pronounced in
male CHR-participants (Fusar-Poli et al., 2013) and in male patients
with ScZ (Lawrie and Abukmeil, 1998; Suzuki et al., 2002).
Accordingly, the large percentage of female CHR-participants may
have contributed to the absence of pronounced GM-alterations in
the current sample.linical high-risk participants for psychosis, Schizophrenia Research,
K. Zikidi et al. / Schizophrenia Research xxx (xxxx) xxx 75. Limitations and Further Steps
We did not assess negative symptoms in CHR-participants
which have been shown to impact on GM in CHR-participants
(Fusar-Poli et al., 2011). In regard to our analytic approach,
several limitations should be acknowledged. The approach we
adopted, while participants-specific, relies on the quality of the
GM/WM segmentation that provides the basis for the volumetric
layering and the cortical thickness computation. Several noise
sources as well as inherent anatomical properties can negatively
affect the quality of the GM/WM segmentation. These include in-
dividual motion in the scanner, poor results of the intensity-based
normalization to remove global inhomogeneities and skull-
stripping as well as inherent differences in GM contrast between
different brain location due to known differences in myelination
(Despotovic et al., 2015).
For these reasons, we visually inspect the outcome of each step
in the analysis as well as the resulting segmentations. Moreover, we
plotted and visually inspected GM-intensity over the cortical sur-
face for each participant to identify well-established patterns due
to myelination differences with high T1-w values to facilitate
comparisons of visual cortices across participants.
Finally, the current results do not include any follow-up data
that could determine whether alterations in GM are predictive for
transitioning to psychosis and other outcome parameters in our
sample, such as psychosocial functioning. Previous studies
(Takahashi et al., 2009; Koutsouleris et al., 2009; Chung and
Cannon, 2015, Pantelis et al., 2003) have highlighted that re-
ductions in GM are related to the development of full-blown psy-
chosis as well as continued poor psycho-social functioning in CHR-
participants (Koutsouleris et al., 2018).
6. Summary
The current study provides further evidence for the absence of
gross anatomical differences in CHR-participants. Our novel
methodological approach identified, however, circumscribed al-
terations in frontal and occipital cortices. The latter may highlight
the novel contribution of deficits in the visual cortex in sub-groups
of CHR-participants that has not been previously described. Follow-
up data are required to determine whether changes in GM-
intensity and thickness are potential biomarkers for the develop-
ment of psychosis and continued poor psychosocial functioning in
CHR-participants.
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